| Peter A Javaheri, MD | |
|
1600 Eureka Rd, Roseville, CA 95661-3027 | |
| (916) 784-4000 | |
| Not Available |
| Full Name | Peter A Javaheri |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 1600 Eureka Rd, Roseville, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023196789 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | G77317 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Oxygen Biotherapeutics, Inc. today announced it has received a $2.075 million, two-year grant from the U.S. Army to study the Company's proprietary Oxycyte PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury.
The Robert Wood Johnson Foundation (RWJF) today announced its selection of Dr. Uwe Jacobs, clinical and executive director of Survivors International, San Francisco, to receive a Community Health Leaders Award. He is one of 10 extraordinary Americans who will receive the RWJF honor for 2009 at a ceremony this evening at the Mayflower Hotel in Washington, D.C.
Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy have been awarded a five-year, $14.5 million grant from the National Institutes of Health to continue leading and expand their research on HIV treatment and care in five Central African nations.
While most American adults may not be patently sick, a vast majority of them still lack full health and vitality. This state of "incomplete" health has resulted in a loss of productivity in the workforce, and potentially increases health care costs in the long term, according to a new Emory University study published in the May issue of the Journal of Environmental and Occupational Health.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched a new test for the detection of mutations in the calreticulin (CALR) gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms (MPN) for the first time at the annual meeting of the American Society of Hematology last month.
› Verified 8 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Oxygen Biotherapeutics, Inc. today announced it has received a $2.075 million, two-year grant from the U.S. Army to study the Company's proprietary Oxycyte PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury.
The Robert Wood Johnson Foundation (RWJF) today announced its selection of Dr. Uwe Jacobs, clinical and executive director of Survivors International, San Francisco, to receive a Community Health Leaders Award. He is one of 10 extraordinary Americans who will receive the RWJF honor for 2009 at a ceremony this evening at the Mayflower Hotel in Washington, D.C.
Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy have been awarded a five-year, $14.5 million grant from the National Institutes of Health to continue leading and expand their research on HIV treatment and care in five Central African nations.
While most American adults may not be patently sick, a vast majority of them still lack full health and vitality. This state of "incomplete" health has resulted in a loss of productivity in the workforce, and potentially increases health care costs in the long term, according to a new Emory University study published in the May issue of the Journal of Environmental and Occupational Health.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched a new test for the detection of mutations in the calreticulin (CALR) gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms (MPN) for the first time at the annual meeting of the American Society of Hematology last month.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter A Javaheri, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Peter A Javaheri, MD 1600 Eureka Rd, Roseville, CA 95661-3027 Ph: (916) 784-4000 |
News Archive
Oxygen Biotherapeutics, Inc. today announced it has received a $2.075 million, two-year grant from the U.S. Army to study the Company's proprietary Oxycyte PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury.
The Robert Wood Johnson Foundation (RWJF) today announced its selection of Dr. Uwe Jacobs, clinical and executive director of Survivors International, San Francisco, to receive a Community Health Leaders Award. He is one of 10 extraordinary Americans who will receive the RWJF honor for 2009 at a ceremony this evening at the Mayflower Hotel in Washington, D.C.
Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy have been awarded a five-year, $14.5 million grant from the National Institutes of Health to continue leading and expand their research on HIV treatment and care in five Central African nations.
While most American adults may not be patently sick, a vast majority of them still lack full health and vitality. This state of "incomplete" health has resulted in a loss of productivity in the workforce, and potentially increases health care costs in the long term, according to a new Emory University study published in the May issue of the Journal of Environmental and Occupational Health.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched a new test for the detection of mutations in the calreticulin (CALR) gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms (MPN) for the first time at the annual meeting of the American Society of Hematology last month.
› Verified 8 days ago
Mr. Jaspreet Singh Dhanjal, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2235 Douglas Blvd Ste 510, Roseville, CA 95661 Phone: 916-446-4449 Fax: 916-446-4370 | |
James H. Heykes, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 | |
Dr. Lakhvir Kaur, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Medical Plaza Dr Ste 200, Roseville, CA 95661 Phone: 916-797-4715 | |
Dr. John T Bakos, M.D., PHD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 729 Sunrise Ave, Suite 610, Roseville, CA 95661 Phone: 916-347-7001 Fax: 916-304-1633 | |
Uma H Gowda, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Medical Plaza Dr Ste 300, Roseville, CA 95661 Phone: 916-782-5106 Fax: 916-878-4941 | |
Rani Reddy Vatti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 |